Who Owns NeuroSense Therapeutics Stock?
NASDAQ: NRSNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:53 AM ET
Ownership breakdown
- Held by institutions
- 1.05%
- Held by insiders
- 31.42%
- Institutional holders
- 13
- Institutions 1.0%
- Insiders 31.4%
- Public and other 67.5%
Who owns NeuroSense Therapeutics stock?
Institutional investors own about 1.0% of NeuroSense Therapeutics's shares, spread across 13 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 31.42% of NRSN.
The largest institutional holders are UBS Group AG (0.29%), Independent Advisor Alliance (0.26%) and Yorkville Advisors Global, LP (0.21%). Together, the top 10 institutions control 1.1% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their NRSN positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NRSN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| UBS Group AG | 5.43K | 0.29% | +121.3% |
| Independent Advisor Alliance | 5.00K | 0.26% | +100.0% |
| Yorkville Advisors Global, LP | 3.90K | 0.21% | 0.0% |
| Commonwealth Equity Services, LLC | 1.14K | 0.06% | 0.0% |
| PNC Financial Services Group, Inc. | 1.06K | 0.06% | 0.0% |
| Pathstone Holdings, LLC | 826 | 0.04% | 0.0% |
| Geode Capital Management, LLC | 794 | 0.04% | 0.0% |
| Xtx Topco Ltd | 574 | 0.03% | +100.0% |
| Creative Planning | 571 | 0.03% | -4.2% |
| HRT Financial LP | 526 | 0.03% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NRSN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 794 | 0.04% |
Frequently asked questions
Who is the largest shareholder of NeuroSense Therapeutics?
UBS Group AG is the largest institutional shareholder of NRSN, owning 0.29% of shares outstanding (5.43K shares) as of its latest 13F filing.
What percentage of NeuroSense Therapeutics is owned by institutions?
Institutions own about 1.0% of NRSN shares and 1.5% of the public float.
How much of NeuroSense Therapeutics do insiders own?
Insiders, such as officers and directors, own about 31.42% of NRSN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.